Gyeonggi-do, South Korea

Won Il Lee

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: C&c Research Laboratories, Accunose Co., Ltd., Accunose Co., Ltd.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Won Il Lee. Retrieved from https://idiyas.com/inventor/won-il-lee-rlcy7gc2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3


 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Hwaseong, KR (2013)
  • Seongnam-si, KR (2015 - 2021)
  • Gyeonggi-do, KR (2017 - 2023)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Won Il Lee**

Introduction

Won Il Lee, an esteemed inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of biomedical technology. With a total of three patents to his name, Lee's innovations focus on enhancing medical treatment and diagnostics, particularly in the realm of antibiotic susceptibility and histamine receptor inhibition. His groundbreaking work has the potential to impact various medical conditions and improve patient outcomes.

Latest Patents

Won Il Lee's latest patents showcase his inventive spirit and commitment to advancing healthcare. One of his notable inventions is an "Apparatus and method for distinguishing antibiotics susceptibility." This innovative method involves several steps, including dispensing and cultivating sample solutions within culture wells. By utilizing magnetic and fluorescent particles that bond with bacteria, Lee's system allows for a precise analysis of antibiotic tolerance and susceptibility through advanced fluorescent imaging techniques.

Another crucial patent is for "Substituted tricyclic heterocycles as histamine 4 receptor inhibitors." This invention relates to novel heterocyclic compounds that show promise in developing drugs for various medical issues, including inflammatory diseases, allergies, and chronic pain conditions. The application of his compounds could lead to advanced treatments for ailments such as asthma, arthritis, and even certain cancers.

Career Highlights

Throughout his career, Won Il Lee has been associated with reputable research institutions, including C&C Research Laboratories and Accunose Co., Ltd. His experiences in these organizations have provided him with valuable insights and expertise in biomedical research and pharmaceutical innovation, allowing him to contribute effectively to the advancement of medical science.

Collaborations

In his journey as an inventor, Lee has collaborated with prominent colleagues, including Sung Oh Ahn and Sun Young Han. These collaborations have facilitated the exchange of ideas and creativity, further enriching his research and leading to groundbreaking innovations.

Conclusion

Won Il Lee stands out as a forward-thinking inventor whose work has the potential to make a significant impact on modern medicine. Through his patents, he addresses critical issues in antibiotic resistance and histamine-related conditions, demonstrating the importance of innovation in healthcare. As he continues to develop new solutions, Lee's contributions will likely inspire further advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…